These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15605284

  • 21. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R, Krause I, Bar Nathan N, Mor M, Dagan A, Weissman I, Frishberg Y, Rachamimov R, Mor E, Davidovits M.
    Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
    [Abstract] [Full Text] [Related]

  • 22. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [Abstract] [Full Text] [Related]

  • 23. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation.
    Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR.
    Pediatr Nephrol; 2024 Nov; 39(11):3317-3331. PubMed ID: 39001911
    [Abstract] [Full Text] [Related]

  • 24. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Jungraithmayr TC, Bulla M, Dippell J, Greiner C, Griebel M, Leichter HE, Plank C, Tönshoff B, Weber LT, Zimmerhackl LB, German MMF Study Group.
    Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
    [Abstract] [Full Text] [Related]

  • 25. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S, Agarwal S, Kalaivani M, Bhowmik D, Singh G, Mahajan S, Dinda A.
    Nephron; 2016 Apr; 132(2):81-5. PubMed ID: 26799973
    [Abstract] [Full Text] [Related]

  • 26. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review.
    Vinai M, Waber P, Seikaly MG.
    Pediatr Transplant; 2010 May; 14(3):314-25. PubMed ID: 20519016
    [Abstract] [Full Text] [Related]

  • 27. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S, Vlachopanos G, Georgalis A, Liapis G, Skalioti C, Zavos G, Boletis JN.
    Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
    [Abstract] [Full Text] [Related]

  • 28. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M, Aala A, Alasfar S, Alachkar N.
    BMC Nephrol; 2020 Jul 02; 21(1):253. PubMed ID: 32615995
    [Abstract] [Full Text] [Related]

  • 29. Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.
    Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN.
    Pediatr Nephrol; 2010 Mar 02; 25(3):529-34. PubMed ID: 19956977
    [Abstract] [Full Text] [Related]

  • 30. Recurrence of FSGS after Kidney Transplantation in Adults.
    Uffing A, Pérez-Sáez MJ, Mazzali M, Manfro RC, Bauer AC, de Sottomaior Drumond F, O'Shaughnessy MM, Cheng XS, Chin KK, Ventura CG, Agena F, David-Neto E, Mansur JB, Kirsztajn GM, Tedesco-Silva H, Neto GMV, Arias-Cabrales C, Buxeda A, Bugnazet M, Jouve T, Malvezzi P, Akalin E, Alani O, Agrawal N, La Manna G, Comai G, Bini C, Muhsin SA, Riella MC, Hokazono SR, Farouk SS, Haverly M, Mothi SS, Berger SP, Cravedi P, Riella LV.
    Clin J Am Soc Nephrol; 2020 Feb 07; 15(2):247-256. PubMed ID: 31974287
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation.
    Shariatmadar S, Noto TA.
    J Clin Apher; 2002 Feb 07; 17(2):78-83. PubMed ID: 12210710
    [Abstract] [Full Text] [Related]

  • 32. Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients.
    Park HS, Hong Y, Sun IO, Chung BH, Kim HW, Choi BS, Park CW, Jin DC, Kim YS, Yang CW.
    Korean J Intern Med; 2014 Jul 07; 29(4):482-8. PubMed ID: 25045296
    [Abstract] [Full Text] [Related]

  • 33. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O.
    Transplantation; 2003 Nov 15; 76(9):1331-9. PubMed ID: 14627912
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan 15; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 35. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
    Seso Simić D, Slavicek J, Bubić Filipi L, Puretić Z, Kes P.
    Acta Med Croatica; 2003 Jan 15; 57(1):53-6. PubMed ID: 12876864
    [Abstract] [Full Text] [Related]

  • 36. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 37. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun 15; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 38. Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort.
    Allard L, Kwon T, Krid S, Bacchetta J, Garnier A, Novo R, Deschenes G, Salomon R, Roussey G, Allain-Launay E.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):954-963. PubMed ID: 28992235
    [Abstract] [Full Text] [Related]

  • 39. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.
    Okamoto M, Koshino K, Sakai K, Nobori S, Matsuyama M, Ushigome H, Okajima H, Masuzawa N, Yoshimura N.
    Clin Transplant; 2011 Jul 01; 25 Suppl 23():53-8. PubMed ID: 21623916
    [Abstract] [Full Text] [Related]

  • 40. Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade.
    Montané B, Abitbol C, Chandar J, Strauss J, Zilleruelo G.
    Pediatr Nephrol; 2003 Aug 01; 18(8):772-7. PubMed ID: 12811652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.